UnitedHealth Group (NYSE:UNH) Earning Positive News Coverage, Analysis Shows

News stories about UnitedHealth Group (NYSE:UNH) have trended positive this week, according to InfoTrie. The research group ranks the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. UnitedHealth Group earned a media sentiment score of 2.34 on their scale. InfoTrie also assigned news coverage about the healthcare conglomerate an news buzz score of 10 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company’s share price in the near term.

These are some of the news articles that may have impacted UnitedHealth Group’s ranking:

Several equities analysts have recently issued reports on the company. Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Saturday. Citigroup raised UnitedHealth Group from a “neutral” rating to a “buy” rating and increased their target price for the company from $247.00 to $280.00 in a research note on Friday. UBS Group started coverage on UnitedHealth Group in a research note on Tuesday, April 23rd. They issued a “neutral” rating and a $238.00 target price on the stock. ValuEngine lowered UnitedHealth Group from a “hold” rating to a “sell” rating in a research note on Thursday, April 18th. Finally, Barclays cut their target price on UnitedHealth Group from $290.00 to $270.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 17th. One research analyst has rated the stock with a sell rating, two have issued a hold rating, eighteen have assigned a buy rating and one has given a strong buy rating to the stock. UnitedHealth Group currently has an average rating of “Buy” and a consensus price target of $290.47.

UNH stock traded up $2.62 during mid-day trading on Friday, reaching $240.59. The company had a trading volume of 4,373,591 shares, compared to its average volume of 8,753,273. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.63. The company has a market cap of $226.15 billion, a price-to-earnings ratio of 18.68, a P/E/G ratio of 1.27 and a beta of 0.74. UnitedHealth Group has a 52 week low of $208.07 and a 52 week high of $287.94.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $3.73 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $3.60 by $0.13. UnitedHealth Group had a return on equity of 25.07% and a net margin of 5.45%. The company had revenue of $60.30 billion during the quarter, compared to analysts’ expectations of $59.72 billion. During the same period last year, the firm posted $3.04 earnings per share. The business’s revenue was up 9.2% on a year-over-year basis. On average, equities research analysts anticipate that UnitedHealth Group will post 14.7 EPS for the current fiscal year.

In related news, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction that occurred on Monday, May 6th. The stock was sold at an average price of $239.02, for a total transaction of $1,195,100.00. Following the completion of the sale, the director now directly owns 77,993 shares of the company’s stock, valued at approximately $18,641,886.86. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CEO David S. Wichmann acquired 20,000 shares of the stock in a transaction on Friday, May 3rd. The shares were bought at an average price of $231.79 per share, for a total transaction of $4,635,800.00. Following the purchase, the chief executive officer now owns 904,367 shares in the company, valued at $209,623,226.93. The disclosure for this purchase can be found here. Over the last ninety days, insiders sold 27,930 shares of company stock valued at $6,746,683. Insiders own 0.87% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “UnitedHealth Group (NYSE:UNH) Earning Positive News Coverage, Analysis Shows” was originally reported by Baseball Daily News and is the sole property of of Baseball Daily News. If you are reading this story on another website, it was stolen and republished in violation of US and international trademark and copyright laws. The correct version of this story can be read at https://www.baseballdailydigest.com/news/2019/05/11/unitedhealth-group-unh-receiving-favorable-media-coverage-infotrie-reports.html.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Further Reading: What is an SEC Filing?

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.